La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Effects of iron complexes on brain calcium homeostasis

Identifieur interne : 001736 ( PascalFrancis/Corpus ); précédent : 001735; suivant : 001737

Effects of iron complexes on brain calcium homeostasis

Auteurs : L. J. Anghileri ; P. Thouvenot ; A. Bertrand

Source :

RBID : Pascal:97-0299238

Descripteurs français

English descriptors

Abstract

The effects of two physiological low molecular weight iron complexes, ferric lactate and ferric adenosine triphosphate (ATP) on brain Ca2+ homeostasis modification, have been studied in vitro and in vivo. In vitro ferric ATP complex shows a higher efficiency as modifier of Ca2+ homeostasis. This higher reactivity and the in vivo observed effect of increased brain uptake of iron from ferric lactate provoked by the presence of ATP, corroborate in vitro results showing an iron transfer from ferric lactate to ATP, as well as the mediator role of ATP in the iron-induced cellular Ca2+ homeostasis modification process. The possible role of this process in Parkinson's disease is discussed.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0091-7370
A02 01      @0 ACLSCP
A03   1    @0 Ann. clin. lab. sci.
A05       @2 27
A06       @2 3
A08 01  1  ENG  @1 Effects of iron complexes on brain calcium homeostasis
A11 01  1    @1 ANGHILERI (L. J.)
A11 02  1    @1 THOUVENOT (P.)
A11 03  1    @1 BERTRAND (A.)
A14 01      @1 Biophysics Laboratory, Medical Faculty, University of Nancy @2 Nancy @3 FRA @Z 1 aut.
A14 02      @1 Nuclear Medicine Department, University of Nancy Medical Center @2 Nancy @3 FRA @Z 2 aut. @Z 3 aut.
A20       @1 210-215
A21       @1 1997
A23 01      @0 ENG
A43 01      @1 INIST @2 16904 @5 354000065519320060
A44       @0 0000 @1 © 1997 INIST-CNRS. All rights reserved.
A45       @0 18 ref.
A47 01  1    @0 97-0299238
A60       @1 P
A61       @0 A
A64 01  1    @0 Annals of clinical and laboratory science
A66 01      @0 USA
C01 01    ENG  @0 The effects of two physiological low molecular weight iron complexes, ferric lactate and ferric adenosine triphosphate (ATP) on brain Ca2+ homeostasis modification, have been studied in vitro and in vivo. In vitro ferric ATP complex shows a higher efficiency as modifier of Ca2+ homeostasis. This higher reactivity and the in vivo observed effect of increased brain uptake of iron from ferric lactate provoked by the presence of ATP, corroborate in vitro results showing an iron transfer from ferric lactate to ATP, as well as the mediator role of ATP in the iron-induced cellular Ca2+ homeostasis modification process. The possible role of this process in Parkinson's disease is discussed.
C02 01  X    @0 002B17G
C03 01  X  FRE  @0 Parkinson maladie @5 01
C03 01  X  ENG  @0 Parkinson disease @5 01
C03 01  X  SPA  @0 Parkinson enfermedad @5 01
C03 02  X  FRE  @0 Homéostasie phosphocalcique @5 04
C03 02  X  ENG  @0 Phosphocalcic homeostasis @5 04
C03 02  X  SPA  @0 Homeostasia fosfocálcica @5 04
C03 03  X  FRE  @0 Calcium @2 NC @2 FR @5 05
C03 03  X  ENG  @0 Calcium @2 NC @2 FR @5 05
C03 03  X  GER  @0 Calcium @2 NC @2 FR @5 05
C03 03  X  SPA  @0 Calcio @2 NC @2 FR @5 05
C03 04  X  FRE  @0 Fer complexe @5 07
C03 04  X  ENG  @0 Iron complex @5 07
C03 04  X  GER  @0 Eisenkomplex @5 07
C03 04  X  SPA  @0 Hierro complejo @5 07
C03 05  X  FRE  @0 In vivo @5 16
C03 05  X  ENG  @0 In vivo @5 16
C03 05  X  SPA  @0 In vivo @5 16
C03 06  X  FRE  @0 Pathogénie @5 17
C03 06  X  ENG  @0 Pathogenesis @5 17
C03 06  X  SPA  @0 Patogenia @5 17
C03 07  X  FRE  @0 Animal @5 20
C03 07  X  ENG  @0 Animal @5 20
C03 07  X  SPA  @0 Animal @5 20
C03 08  X  FRE  @0 Souris @5 21
C03 08  X  ENG  @0 Mouse @5 21
C03 08  X  SPA  @0 Ratón @5 21
C03 09  X  FRE  @0 Rat @5 22
C03 09  X  ENG  @0 Rat @5 22
C03 09  X  SPA  @0 Rata @5 22
C03 10  X  FRE  @0 In vitro @5 23
C03 10  X  ENG  @0 In vitro @5 23
C03 10  X  SPA  @0 In vitro @5 23
C03 11  X  FRE  @0 Culture cellulaire @5 24
C03 11  X  ENG  @0 Cell culture @5 24
C03 11  X  SPA  @0 Cultivo celular @5 24
C07 01  X  FRE  @0 Rodentia @2 NS
C07 01  X  ENG  @0 Rodentia @2 NS
C07 01  X  SPA  @0 Rodentia @2 NS
C07 02  X  FRE  @0 Mammalia @2 NS
C07 02  X  ENG  @0 Mammalia @2 NS
C07 02  X  SPA  @0 Mammalia @2 NS
C07 03  X  FRE  @0 Vertebrata @2 NS
C07 03  X  ENG  @0 Vertebrata @2 NS
C07 03  X  SPA  @0 Vertebrata @2 NS
C07 04  X  FRE  @0 Système nerveux pathologie @5 37
C07 04  X  ENG  @0 Nervous system diseases @5 37
C07 04  X  SPA  @0 Sistema nervioso patología @5 37
C07 05  X  FRE  @0 Système nerveux central pathologie @5 38
C07 05  X  ENG  @0 Central nervous system disease @5 38
C07 05  X  SPA  @0 Sistema nervosio central patología @5 38
C07 06  X  FRE  @0 Encéphale pathologie @5 39
C07 06  X  ENG  @0 Cerebral disorder @5 39
C07 06  X  SPA  @0 Encéfalo patología @5 39
C07 07  X  FRE  @0 Extrapyramidal syndrome @5 40
C07 07  X  ENG  @0 Extrapyramidal syndrome @5 40
C07 07  X  SPA  @0 Extrapiramidal síndrome @5 40
C07 08  X  FRE  @0 Maladie dégénérative @5 41
C07 08  X  ENG  @0 Degenerative disease @5 41
C07 08  X  SPA  @0 Enfermedad degenerativa @5 41
N21       @1 167

Format Inist (serveur)

NO : PASCAL 97-0299238 INIST
ET : Effects of iron complexes on brain calcium homeostasis
AU : ANGHILERI (L. J.); THOUVENOT (P.); BERTRAND (A.)
AF : Biophysics Laboratory, Medical Faculty, University of Nancy/Nancy/France (1 aut.); Nuclear Medicine Department, University of Nancy Medical Center/Nancy/France (2 aut., 3 aut.)
DT : Publication en série; Niveau analytique
SO : Annals of clinical and laboratory science; ISSN 0091-7370; Coden ACLSCP; Etats-Unis; Da. 1997; Vol. 27; No. 3; Pp. 210-215; Bibl. 18 ref.
LA : Anglais
EA : The effects of two physiological low molecular weight iron complexes, ferric lactate and ferric adenosine triphosphate (ATP) on brain Ca2+ homeostasis modification, have been studied in vitro and in vivo. In vitro ferric ATP complex shows a higher efficiency as modifier of Ca2+ homeostasis. This higher reactivity and the in vivo observed effect of increased brain uptake of iron from ferric lactate provoked by the presence of ATP, corroborate in vitro results showing an iron transfer from ferric lactate to ATP, as well as the mediator role of ATP in the iron-induced cellular Ca2+ homeostasis modification process. The possible role of this process in Parkinson's disease is discussed.
CC : 002B17G
FD : Parkinson maladie; Homéostasie phosphocalcique; Calcium; Fer complexe; In vivo; Pathogénie; Animal; Souris; Rat; In vitro; Culture cellulaire
FG : Rodentia; Mammalia; Vertebrata; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative
ED : Parkinson disease; Phosphocalcic homeostasis; Calcium; Iron complex; In vivo; Pathogenesis; Animal; Mouse; Rat; In vitro; Cell culture
EG : Rodentia; Mammalia; Vertebrata; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease
GD : Calcium; Eisenkomplex
SD : Parkinson enfermedad; Homeostasia fosfocálcica; Calcio; Hierro complejo; In vivo; Patogenia; Animal; Ratón; Rata; In vitro; Cultivo celular
LO : INIST-16904.354000065519320060
ID : 97-0299238

Links to Exploration step

Pascal:97-0299238

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Effects of iron complexes on brain calcium homeostasis</title>
<author>
<name sortKey="Anghileri, L J" sort="Anghileri, L J" uniqKey="Anghileri L" first="L. J." last="Anghileri">L. J. Anghileri</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Biophysics Laboratory, Medical Faculty, University of Nancy</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Thouvenot, P" sort="Thouvenot, P" uniqKey="Thouvenot P" first="P." last="Thouvenot">P. Thouvenot</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Nuclear Medicine Department, University of Nancy Medical Center</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bertrand, A" sort="Bertrand, A" uniqKey="Bertrand A" first="A." last="Bertrand">A. Bertrand</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Nuclear Medicine Department, University of Nancy Medical Center</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">97-0299238</idno>
<date when="1997">1997</date>
<idno type="stanalyst">PASCAL 97-0299238 INIST</idno>
<idno type="RBID">Pascal:97-0299238</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001736</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Effects of iron complexes on brain calcium homeostasis</title>
<author>
<name sortKey="Anghileri, L J" sort="Anghileri, L J" uniqKey="Anghileri L" first="L. J." last="Anghileri">L. J. Anghileri</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Biophysics Laboratory, Medical Faculty, University of Nancy</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Thouvenot, P" sort="Thouvenot, P" uniqKey="Thouvenot P" first="P." last="Thouvenot">P. Thouvenot</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Nuclear Medicine Department, University of Nancy Medical Center</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bertrand, A" sort="Bertrand, A" uniqKey="Bertrand A" first="A." last="Bertrand">A. Bertrand</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Nuclear Medicine Department, University of Nancy Medical Center</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Annals of clinical and laboratory science</title>
<title level="j" type="abbreviated">Ann. clin. lab. sci.</title>
<idno type="ISSN">0091-7370</idno>
<imprint>
<date when="1997">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Annals of clinical and laboratory science</title>
<title level="j" type="abbreviated">Ann. clin. lab. sci.</title>
<idno type="ISSN">0091-7370</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animal</term>
<term>Calcium</term>
<term>Cell culture</term>
<term>In vitro</term>
<term>In vivo</term>
<term>Iron complex</term>
<term>Mouse</term>
<term>Parkinson disease</term>
<term>Pathogenesis</term>
<term>Phosphocalcic homeostasis</term>
<term>Rat</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Parkinson maladie</term>
<term>Homéostasie phosphocalcique</term>
<term>Calcium</term>
<term>Fer complexe</term>
<term>In vivo</term>
<term>Pathogénie</term>
<term>Animal</term>
<term>Souris</term>
<term>Rat</term>
<term>In vitro</term>
<term>Culture cellulaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The effects of two physiological low molecular weight iron complexes, ferric lactate and ferric adenosine triphosphate (ATP) on brain Ca
<sup>2+</sup>
homeostasis modification, have been studied in vitro and in vivo. In vitro ferric ATP complex shows a higher efficiency as modifier of Ca
<sup>2+</sup>
homeostasis. This higher reactivity and the in vivo observed effect of increased brain uptake of iron from ferric lactate provoked by the presence of ATP, corroborate in vitro results showing an iron transfer from ferric lactate to ATP, as well as the mediator role of ATP in the iron-induced cellular Ca
<sup>2+</sup>
homeostasis modification process. The possible role of this process in Parkinson's disease is discussed.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0091-7370</s0>
</fA01>
<fA02 i1="01">
<s0>ACLSCP</s0>
</fA02>
<fA03 i2="1">
<s0>Ann. clin. lab. sci.</s0>
</fA03>
<fA05>
<s2>27</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Effects of iron complexes on brain calcium homeostasis</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>ANGHILERI (L. J.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>THOUVENOT (P.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>BERTRAND (A.)</s1>
</fA11>
<fA14 i1="01">
<s1>Biophysics Laboratory, Medical Faculty, University of Nancy</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Nuclear Medicine Department, University of Nancy Medical Center</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>210-215</s1>
</fA20>
<fA21>
<s1>1997</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>16904</s2>
<s5>354000065519320060</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 1997 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>18 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>97-0299238</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Annals of clinical and laboratory science</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>The effects of two physiological low molecular weight iron complexes, ferric lactate and ferric adenosine triphosphate (ATP) on brain Ca
<sup>2+</sup>
homeostasis modification, have been studied in vitro and in vivo. In vitro ferric ATP complex shows a higher efficiency as modifier of Ca
<sup>2+</sup>
homeostasis. This higher reactivity and the in vivo observed effect of increased brain uptake of iron from ferric lactate provoked by the presence of ATP, corroborate in vitro results showing an iron transfer from ferric lactate to ATP, as well as the mediator role of ATP in the iron-induced cellular Ca
<sup>2+</sup>
homeostasis modification process. The possible role of this process in Parkinson's disease is discussed.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Homéostasie phosphocalcique</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Phosphocalcic homeostasis</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Homeostasia fosfocálcica</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Calcium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Calcium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="GER">
<s0>Calcium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Calcio</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Fer complexe</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Iron complex</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="GER">
<s0>Eisenkomplex</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Hierro complejo</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>In vivo</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>In vivo</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>In vivo</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Pathogénie</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Pathogenesis</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Patogenia</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Souris</s0>
<s5>21</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Mouse</s0>
<s5>21</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Ratón</s0>
<s5>21</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Rat</s0>
<s5>22</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Rat</s0>
<s5>22</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Rata</s0>
<s5>22</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>In vitro</s0>
<s5>23</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>In vitro</s0>
<s5>23</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>In vitro</s0>
<s5>23</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Culture cellulaire</s0>
<s5>24</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Cell culture</s0>
<s5>24</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Cultivo celular</s0>
<s5>24</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fN21>
<s1>167</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 97-0299238 INIST</NO>
<ET>Effects of iron complexes on brain calcium homeostasis</ET>
<AU>ANGHILERI (L. J.); THOUVENOT (P.); BERTRAND (A.)</AU>
<AF>Biophysics Laboratory, Medical Faculty, University of Nancy/Nancy/France (1 aut.); Nuclear Medicine Department, University of Nancy Medical Center/Nancy/France (2 aut., 3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Annals of clinical and laboratory science; ISSN 0091-7370; Coden ACLSCP; Etats-Unis; Da. 1997; Vol. 27; No. 3; Pp. 210-215; Bibl. 18 ref.</SO>
<LA>Anglais</LA>
<EA>The effects of two physiological low molecular weight iron complexes, ferric lactate and ferric adenosine triphosphate (ATP) on brain Ca
<sup>2+</sup>
homeostasis modification, have been studied in vitro and in vivo. In vitro ferric ATP complex shows a higher efficiency as modifier of Ca
<sup>2+</sup>
homeostasis. This higher reactivity and the in vivo observed effect of increased brain uptake of iron from ferric lactate provoked by the presence of ATP, corroborate in vitro results showing an iron transfer from ferric lactate to ATP, as well as the mediator role of ATP in the iron-induced cellular Ca
<sup>2+</sup>
homeostasis modification process. The possible role of this process in Parkinson's disease is discussed.</EA>
<CC>002B17G</CC>
<FD>Parkinson maladie; Homéostasie phosphocalcique; Calcium; Fer complexe; In vivo; Pathogénie; Animal; Souris; Rat; In vitro; Culture cellulaire</FD>
<FG>Rodentia; Mammalia; Vertebrata; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Parkinson disease; Phosphocalcic homeostasis; Calcium; Iron complex; In vivo; Pathogenesis; Animal; Mouse; Rat; In vitro; Cell culture</ED>
<EG>Rodentia; Mammalia; Vertebrata; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<GD>Calcium; Eisenkomplex</GD>
<SD>Parkinson enfermedad; Homeostasia fosfocálcica; Calcio; Hierro complejo; In vivo; Patogenia; Animal; Ratón; Rata; In vitro; Cultivo celular</SD>
<LO>INIST-16904.354000065519320060</LO>
<ID>97-0299238</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001736 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001736 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:97-0299238
   |texte=   Effects of iron complexes on brain calcium homeostasis
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024